Delivery Order SPE2DR25D1109-SPE2DR26FFK7X
- Not listed
- On August 14, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,496.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens. This non-competitive, firm fixed-price delivery order is set to be completed by August 15, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete fulfillment under the company's broader contract vehicle with DLA. AmerisourceBergen Drug Corp, a...
- On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,721.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectables. The contract is a firm fixed-price delivery order with an ultimate completion date of January 14, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a subsidiary...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,180.52 on December 10, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units). This firm fixed-price delivery order, with an ultimate completion date of December 11, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contract was competitively awarded with no set-aside designation and will be performed at...
- On January 8, 2026, the Defense Logistics Agency awarded a delivery order valued at $2,189.43 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors with 0.5 mL dosage units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 9, 2026, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made on a full and open competitive basis with no set-aside designation....
- On November 6, 2025, the Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens valued at $1,116.83. This firm fixed-price delivery order, which has an ultimate completion date of November 7, 2025, was competitively awarded with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,503.93 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors on November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract was performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 18, 2025. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $2,374.50 under a firm fixed-price contract. This is a non-set-aside competitive award with an ultimate completion date of December 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's larger...
- On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $11,296.66 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen (0.5 ml). This firm fixed-price delivery order, with an ultimate completion date of January 12, 2026, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this pharmaceutical supply delivery. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a ceiling value of $15,344.90. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by November 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military...
- The Defense Logistics Agency awarded a delivery order valued at $1,739.62 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen injectors on December 11, 2025. This firm fixed-price delivery order, with an ultimate completion date of December 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will take place at the...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFK7XDelivery Order
On January 14, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,944.36 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors. This firm fixed-price contract, with an ultimate completion date of January 15, 2026, represents a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999.00 and running through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (which operates under the AmerisourceBergen brand), is a major pharmaceutical distributor serving critical federal medical procurement needs for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a diverse range of pharmaceutical products across multiple therapeutic domains. This delivery order for Trulicity, a diabetes management medication, exemplifies the types of specialty pharmaceutical commodities the company routinely delivers through its federal contracts to support Defense Health Agency, U.S. Coast Guard, and other government healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 1/13/26 |